Detalle Publicación

ARTÍCULO

Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

Autores: Barreiro-Pérez, M.; Cabeza, B.; Calvo, D.; Reyes-Juárez, J. L.; Datino, T.; Vano Galvan, E.; Maceira González, A. M.; Delgado Sanchez-Gracian, C..; Prat-González, S.; Perea, R. J.; Bastarrika Alemañ, Gorka; Sánchez, M.; Jiménez-Borreguero, L. J.; Fernandez-Golfin Lobán, C.; Rodriguez Palomares, J. F.; Tolosanar, J. M.; Hidalgo Pérez, J. A.; Pérez-David, E.; Bertomeu-González, V.; Cuéllar, H.
Título de la revista: RADIOLOGIA
ISSN: 0033-8338
Volumen: 65
Número: 3
Páginas: 269 - 284
Fecha de publicación: 2023
Resumen:
Magnetic resonance has become a first-line imaging modality in various clinical scenarios. The number of patients with different cardiovascular devices, including cardiac implantable electronic devices, has increased exponentially. Although there have been reports of risks associated with exposure to magnetic resonance in these patients, the clinical evidence now supports the safety of performing these studies under specific conditions and following recommendations to minimize possible risks. This document was written by the Working Group on Cardiac Magnetic Resonance Imaging and Cardiac Computed Tomography of the Spanish Society of Cardiology (SEC-GT CRMTC), the Heart Rhythm Association of the Spanish Society of Cardiology (SEC-Heart Rhythm Association), the Spanish Society of Medical Radiology (SERAM), and the Spanish Society of Cardiothoracic Imaging (SEICAT). The document reviews the clinical evidence available in this field and establishes a series of recommendations so that patients with cardiovascular devices can safely access this diagnostic tool. (c) 2022 SERAM. Published by Elsevier Espana, S.L.U. All rights reserved.
DOI: https://doi.org/10.1016/j.rxeng.2022.09.014
Impacto:
Google Scholar